Pharming Says FDA Grants Priority Review For Joenja In Children With APDS Weighing 13 To 27 Kg; Decision Due January 30, 2027
Share
Why It Matters
Pharming got the FDA to speed up review of their medicine Joenja. This is a good sign, but the final decision won't come until next year.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.